How Antiviral Medications Target Cold Sores
Understanding the Herpes Simplex Virus
Cold sores are caused by herpes simplex virus type 1 (HSV-1), which remains dormant in nerve cells after initial infection. When triggered by factors like stress, illness, or sun exposure, the virus reactivates and travels to the skin surface, causing the characteristic blisters. The virus goes through distinct stages: tingling and itching (days 1-2), blister formation (days 2-4), weeping stage (days 4-5), crusting (days 5-8), and healing (days 8-10).
How Aciclovir Works Against Cold Sores
Aciclovir is a nucleoside analogue that mimics one of the building blocks of viral DNA. When HSV-1 attempts to replicate, it incorporates aciclovir into its DNA chain, which terminates further DNA synthesis. This mechanism specifically targets infected cells whilst leaving healthy cells largely unaffected. The medication is converted to its active form by viral enzymes, making it highly selective for virus-infected tissue.
Oral vs Topical Treatment Options
Aciclovir 400mg tablets provide systemic treatment, reaching the virus through the bloodstream. This approach may be more effective for frequent or severe outbreaks. EverydayMeds offers prescription aciclovir tablets for eligible patients following online consultation. Topical aciclovir 5% cream works locally at the application site and may be suitable for mild, infrequent outbreaks. Some patients benefit from combination therapy using both oral and topical treatments.
Alternative Antiviral Options
Valaciclovir, available as Valtrex or generic tablets, is a prodrug of aciclovir with better oral absorption. This allows for less frequent dosing whilst maintaining effectiveness. EverydayMeds stocks both valaciclovir 500mg tablets and branded Valtrex for patients who may benefit from this alternative. The choice between treatments depends on individual factors including outbreak frequency, severity, and patient preference.
Optimising Treatment Effectiveness
Early treatment initiation is crucial for maximum benefit. Starting antiviral therapy within the first 24-48 hours of symptoms (during the tingling stage) may reduce outbreak duration and severity. Some patients with frequent outbreaks may benefit from suppressive therapy, taking daily antiviral medication to prevent recurrences. This approach requires medical supervision and regular review. Patients should also consider trigger avoidance strategies including stress management, sun protection, and maintaining good general health.
